Abstract:Acute myocardial infarction without persistent ST-segment elevation is a serious medical problem that significantly increases cardiovascular mortality and morbidity. Therefore, timely accurate diagnosis is crucial for adequate treatment of these patients, better survival and improved quality of life. It is characterized by a clinical picture of acute chest discomfort that may occur in the form of typical anginal problems or as the equivalent of acute chest pain. Changes in the electrocardiogram are varied, from transient ST-segment elevation, persistent or transient ST-segment depression, T-wave inversion, flattened T-wave, or pseudonormalization of the T-wave, to normal electrocardiographic recording. The latest guidelines of the European Society of Cardiology advise determining the value of cardio-specific enzymes from the patient's blood, namely high-sensitivity cardiac troponin T or I immediately upon admission to the health institution and repeated one hour after admission (0h / 1h algorithm). Echocardiographic examination is recommended in all patients as a routine procedure before admission or during hospitalization. Coronary CT angiography for the anatomical evaluation of coronary heart disease is important in patients with a low to moderate probability of an acute coronary event. Drug treatment in these patients involves the use of dual antiplatelet therapy to determine the ischemic risk of the patient as well as the risk of bleeding. Pre-treatment with the use of primarily P2Y12 receptor inhibitors is not recommended in routine clinical practice. In patients who have undergone revascularization and stent implantation, dual antiplatelet therapy is recommended for 12 months, except in cases where there are contraindications or increased hemorrhagic risk. Patients who require long-term use of oral anticoagulant therapy after a short period of triple antiplatelet therapy up to 1 week after the acute event, continue dual antiplatelet therapy, using new anticoagulants at the recommended dose to prevent stroke and one oral antiplatelet drug. Invasive coronary angiography can be performed according to the patient's risk immediately after admission to a health institution (within 2 hours) in very high-risk patients or as an early treatment strategy, within 24 hours of admission in high-risk patients. To perform an invasive intervention, a radial approach is advised, as well as the implantation of drug-coated stents. In patients in whom it is not possible to perform myocardial revascularization by percutaneous coronary intervention, revascularization with coronary artery bypass grafts is recommended. In the long-term follow-up of these patients, after an acute coronary event, it is advisable to change life habits with pharmacological treatment, which reduces mortality and improves the quality of life.

[Management of acute coronary syndromes 2023 European Society of Cardiology guidelines]

A Critical Appraisal of the 2023 European Society of Cardiology Guidelines for the Management of Acute Coronary Syndrome

Diagnosis and Management of Acute Coronary Syndrome: What is New and Why? Insight From the 2020 European Society of Cardiology Guidelines

Clinical Analysis of 373 Patients with Non-ST Elevation Acute Coronary Syndrome in a Teaching Hospital

2023 European Society of Cardiology guidelines for the management of acute coronary syndromes

National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the management of acute coronary syndromes 2016

The new ESC acute coronary syndrome guideline and its impact in the CPU and emergency department setting

Updates and current recommendations for the management of patients with non-ST-elevation acute coronary syndromes: what it means for clinical practice

Revised guidelines for the management of non-ST-segment elevation acute coronary syndromes

An update on management of the patient presenting with non-ST-elevation acute coronary syndromes

Antithrombotic therapy in patients with acute coronary syndrome: similarities and differences between a European expert consensus document and the 2023 European Society of Cardiology guidelines

A Case-Based Approach to the Management of Patients with Chronic Coronary Disease: Updates from the 2023 AHA/ACC Guidelines

2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.

Approach to non-ST-segment elevation acute coronary syndrome in the emergency department: risk stratification and treatment strategies

Eurasian clinical guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndrome (NSTE-ACS)

Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European Society of Cardiology

Acute coronary syndrome without persistent elevation of the ST segment: New recommendations

Management of acute coronary syndrome: achievements and goals still to pursue. Novel developments in diagnosis and treatment

European Resuscitation Council Guidelines 2021: First aid

Antiplatelet and Anticoagulation Treatment in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: Comparison of the Updated North American and European Guidelines

Anticoagulants in ischemia-guided management of non-ST-elevation acute coronary syndromes